OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Gastroenterology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Medical malpractice and gastrointestinal endoscopy	46
Editorial introductions	45
Editorial introductions	38
Updates and innovations in therapeutic endoscopy	38
Biologics, small molecule therapies and surgery in small bowel Crohn's disease	35
Management of upper gastrointestinal symptoms in patients with autoimmune gastritis	34
Clostridioides difficile infections; new treatments and future perspectives	31
Hepatitis E virus: has anything changed?	29
Cholangioscopy for biliary diseases	27
Using nutrition to help recovery from infections	26
Stomach and duodenum: what's current in 2023	24
Double-edged sword: impact of fecal microbiome transplants on the gut resistome	22
Editorial introductions	21
Role of hyperbaric oxygen therapy in patients with inflammatory bowel disease	20
Current and future microbiome-based therapies in inflammatory bowel disease	19
Carnitine derivatives beyond fatigue: an update	18
Considerations when starting patients on multiple biologics and small molecules	18
Prognostic modeling in biliary diseases	17
Micronutrient status and protein-energy malnutrition in free-living older adults: a current perspective	16
Refractory eosinophilic esophagitis: what to do when the patient has not responded to proton pump inhibitors, steroids and diet	16
The gut virome in health and disease: new insights and associations	16
A review of deep learning and radiomics approaches for pancreatic cancer diagnosis from medical imaging	16
Clinical and translational markers of severity and prognosis in chronic pancreatitis	15
COVID-19 vaccine-induced liver injury	15
Implications of Paneth cell dysfunction on gastrointestinal health and disease	15

Gastric submucosal mass lesions	14
Endoluminal bariatric and metabolic therapies: state-of-the-art	14
Gastroparesis: time for a paradigm change	14
Tight junction proteins and biliary diseases	13
Ergonomic wellness for the trainee in gastrointestinal endoscopy	13
Celiac disease and nonceliac enteropathies	13
Endoscopic management of colonic perforations	13
Bidirectional relationship between acute pancreatitis and pancreatic cancer	13
Machine and deep learning in inflammatory bowel disease	13
Laparoscopic heller myotomy versus peroral endoscopic myotomy for the treatment of achalasia	13
The rise of antibiotic resistance in Campylobacter	12
Advances in the evaluation and treatment of autoimmune hepatitis	12
Advances in endoscopic management of colonic diverticular bleeding	12
Editorial introductions	12
Managing the older adult with inflammatory bowel disease: is age just a number?	11
Alterations in microbiome associated with acute pancreatitis	11
Nutritional aspects in patients with gastroparesis	11
Diagnosis and management of acute lower gastrointestinal bleeding	11
Editorial introductions	10
Intestinal proteases	10
Probiotics in irritable bowel syndrome and inflammatory bowel disease: review of mechanisms and effectiveness	10
Endoscopic approaches to small intestinal strictures	10
Histological evaluation in biliary diseases	10
Bile acid diarrhea – as bad as it gets?	10
Updates on therapeutic endoscopic ultrasound	10
Endoscopic approaches to the management of hemorrhoids	10
The spectrum of diabetes in acute and chronic pancreatitis	9
Integrating new and emerging therapies into inflammatory bowel disease clinical practice	9
Check this out: treatment paradigms in immune-checkpoint inhibitor colitis	9
Pathophysiology updates: gastroduodenal injury and repair mechanisms	9
The status of endoscopic therapies for gastroesophageal reflux disease	9
Diet and carcinogenesis of gastric cancer	9
Updates in endoscopic management of ampullary and duodenal adenomas	9
Intestinal transplantation: an update	8
Advances in colon-targeted drug technologies	8
Bulking agents in gastrointestinal endoscopy: present applications and future advances	8
Update on applications of endoscopic cryotherapy in the gastrointestinal tract	8
Editorial: The next-generation toolkit for exploring biliary diseases	8
Editorial introductions	8
Imaging abnormalities of the pancreas in diabetes: implications for diagnosis and treatment	8
Editorial introductions	8
Neoadjuvant therapy in pancreatic cancer: a review and update on recent trials	8
How provocative tests in addition to wet swallows during high-resolution manometry can direct clinical management	7
Management of refractory inflammatory bowel disease	7
Endoscopic therapy for gastroesophageal reflux disease: where are we, where are we going?	7
Update on extraesophageal manifestations of gastroesophageal reflux	7
The vermiform cecal appendix, expendable or essential? A narrative review	7
Small bowel intussusception – aetiology & management	7
Editorial introduction	7
Identifying individuals at risk of esophageal adenocarcinoma: challenges, existing tools and future steps	7

The use of artificial intelligence in colonoscopic evaluations	7
Role of endoscopy on enteral feeding	7
Retention of small bowel capsule endoscopy	6
Targeting osteopontin to treat primary sclerosing cholangitis	6
Nutritional deficiencies in alcohol use disorder/alcohol-associated liver disease	6
Immune markers of severe acute pancreatitis	6
Interpretation of serum pancreatic enzymes in pancreatic and nonpancreatic conditions	6
Risk and factors determining diabetes after mild, nonnecrotizing acute pancreatitis	6
Mast cell activation and nutritional disorders in patients with hypermobility	6
Editorial: Stomach and duodenum: what is current in 2022?	6
Intestinal microbiome in short bowel syndrome: diagnostic and therapeutic opportunities	6
Editorial: The future of inflammatory bowel disease management	6
The role of the microbiome in liver disease	6
A ramble through the small bowel	6
Small intestinal bacterial overgrowth: current update	5
The evaluation of liver abnormalities in inflammatory bowel disease patients	5
Population level screening for celiac disease: is now the time?	5
The role of the fibroblast in Barrett's esophagus and esophageal adenocarcinoma	5
Colon polyps: updates in classification and management	5
Reviewing the impact of obesity on inflammatory bowel disease and considerations for optimizing management	5
Bile acids as metabolic regulators: an update	5
Imaging of the biliary tract	5
Neuro-immune cell interactions in the regulation of intestinal immune homeostasis	5
A Practical guide to selecting and using new Crohn's disease therapies	5
Road map to small bowel endoscopy quality indicators	5
Update on pain management in acute pancreatitis	5
Lichen planus esophagitis	5
Comparative efficacy trials in inflammatory bowel disease: current and future implications for practice	5
Incretin mimetics and acute pancreatitis: enemy or innocent bystander?	4
Noninvasive evaluation of fibrosis in adult biliary diseases	4
Editorial introductions	4
The use of ultrasound in colonic and perianal diseases	4
Small bowel obstruction: what a gastroenterologist needs to know	4
Selection of endoscopic resection technique for large colorectal lesion treatment	4
Clostridium difficile in inflammatory bowel disease	4
Precision medicine: how multiomics will shape the future of inflammatory bowel disease?	4
Editorial introductions	4
Metabolic dysfunction and nonalcoholic fatty liver disease risk in individuals with a normal body mass index	4
Endoscopic ultrasound-guided radiofrequency ablation of pancreatic tumors	4
A practical guide to selecting and using new ulcerative colitis therapies	4
Diet as a treatment for inflammatory bowel disease: is it ready for prime time?	4
Editorial: The fight against infectious diseases begins anew	4
Integrins in biliary injury and fibrosis	4
Endobariatrics: well past infancy and maturing rapidly	4